Total liabilities ToolGen 2014-2024
In 2024, the total value of liabilities held by ToolGen amounted to around 17.04 billion South Korean won. This represents a significant decrease compared to the previous year. ToolGen is a South Korean biotech company based on CRISPR genome editing technology.